Aspergillus-specific IgM/IgG antibody serostatus of patients hospitalized with moderate-critical COVID-19 in Uganda
View/ Open
Date
2022-09-03Author
Bongomin, Felix
Kwizera, Richard
Mande, Emmanuel
Aloyo, Sharley Melissa
Achan, Beatrice
Namusobya, Martha
Sereke, Senai Goitom
Batte, Charles
Kiguli, Sarah
Baruch Baluku, Joseph
Joloba, Moses L
Kirenga, Bruce J
Metadata
Show full item recordAbstract
Invasive pulmonary aspergillosis is known to complicate the coronavirus diseases-2019 (COVID-19), especially those with crit ical illness. We investigated the baseline anti-Aspergillus antibody serostatus of patients with moderate-critical COVID-19 hos pitalized at 3 COVID-19 Treatment Units in Uganda. All 46 tested patients, mean age 30, and 11% with underlying respiratory
disease had a negative serum anti-Aspergillus IgM/IgG antibody immunochromatographic test on day 3 (mean) of symptom
onset (range 1-26), but follow up specimens to assess seroconversion were not available.
Collections
- Research Articles [49]